Pentoxifylline administration changes protein expression profile of coronary artery disease patients

Gene

Volumn 487, Issue 1, 2011, Pages 107-111

  Shamsara, Jamal ^a   Behravan, Javad ^a   Falsoleiman, Homa ^b   Mohammadpour, Amir Hooshang ^a   Rendeirs, Joerg ^c   Ramezani, Mohammad ^d,e  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammation; PBMCs; Proteome

Indexed keywords

ALPHA ENOLASE; BETA TUBULIN; CALGRANULIN B; CYCLOPHILIN A; HEAT SHOCK PROTEIN 70; METHYLTRANSFERASE; PENTOXIFYLLINE; PLACEBO; PROTEIN ISOASPARTATE(DEXTRO ASPARTATE) O METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; FEMALE; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; UPREGULATION;

CALGRANULIN B; CORONARY ARTERY DISEASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PENTOXIFYLLINE; PEPTIDYLPROLYL ISOMERASE; PHOSPHODIESTERASE INHIBITORS; PHOSPHOPYRUVATE HYDRATASE; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBULIN;

EID: 80052314660     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.07.020     Document Type: Article

References (36)

1. Arora K., et al. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 2005, 175:517-522.
2. Baetta R., Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives. Atherosclerosis 2010, 210:1-13.
3. Beere H.M., Green D.R. Stress management - heat shock protein-70 and the regulation of apoptosis. Trends Cell Biol. 2001, 11:6-10.
4. Bjork P., et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 2009, 7:e97.
5. Blanco-Colio L.M., et al. Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST. Kidney Int. Suppl. 2008, S60-S63.
6. Chen Y.M., Tu C.J., Hung K.Y., Wu K.D., Tsai T.J., Hsieh B.S. Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation. Br. J. Pharmacol. 2003, 138:950-958.
7. Corrado E., Rizzo M., Coppola G., Fattouch K., Novo G., Marturana I., Ferrara F., Novo S. An update on the role of markers of inflammation in atherosclerosis. J. Atheroscler. Thromb. 2010, 17:1-11.
8. Dai Y., Hu C., Huang Y., Huang H., Liu J., Lv T. A proteomic study of peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 2008, 17:799-804.
9. Devaraj S., Jialal I. Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity. Arch. Pathol. Lab. Med. 2008, 132:1432-1435.
10. Dotzlaw H., Schulz M., Eggert M., Neeck G. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta 2004, 1696:121-129.
11. Fernandes J.L., et al. Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease-a randomized placebo-controlled study. Atherosclerosis 2008, 196:434-442.
12. Fuchs D., Piller R., Linseisen J., Daniel H., Wenzel U. The human peripheral blood mononuclear cell proteome responds to a dietary flaxseed-intervention and proteins identified suggest a protective effect in atherosclerosis. Proteomics 2007, 7:3278-3288.
13. Fuchs D., et al. Proteomic biomarkers of peripheral blood mononuclear cells obtained from postmenopausal women undergoing an intervention with soy isoflavones. Am. J. Clin. Nutr. 2007, 86:1369-1375.
14. *). Annu. Rev. Immunol. 2009, 27:165-197.
15. Gomez-Garre D., Munoz-Pacheco P., Gonzalez-Rubio M.L., Aragoncillo P., Granados R., Fernandez-Cruz A. Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect. Br. J. Pharmacol. 2009, 156:1218-1227.
16. Hu W.L., Qian S.B., Li J.J. Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. Cytokine 2007, 40:201-206.
17. Jin Z.G., et al. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ. Res. 2000, 87:789-796.
18. Kannel W.B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005, 40:1215-1220.
19. Kinlay S., et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 2004, 110:386-391.
20. Latchman D.S. Heat shock proteins and cardiac protection. Cardiovasc. Res. 2001, 51:637-646.
21. Liang L., Major T., Bocan T. Characterization of the promoter of human extracellular matrix metalloproteinase inducer (EMMPRIN). Gene 2002, 282:75-86.
22. Lopez-Alemany R., et al. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase. Am. J. Hematol. 2003, 72:234-242.
23. Maiti R., Agrawal N.K., Dash D., Pandey B.L. Effect of pentoxifylline on inflammatory burden, oxidative stress and platelet aggregability in hypertensive type 2 diabetes mellitus patients. Vascul. Pharmacol. 2007, 47:118-124.
24. Meng X., Harken A.H. The interaction between Hsp70 and TNF-alpha expression: a novel mechanism for protection of the myocardium against post-injury depression. Shock 2002, 17:345-353.
25. Mhyre T.R., et al. Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium. Neurobiol. Aging 2008, 29:1631-1643.
26. Patel S., Celermajer D.S., Bao S. Atherosclerosis-underlying inflammatory mechanisms and clinical implications. Int. J. Biochem. Cell Biol. 2008, 40:576-580.
27. Prasad K., Lee P. Suppression of hypercholesterolemic atherosclerosis by pentoxifylline and its mechanism. Atherosclerosis 2007, 192:313-322.
28. Serrano C.V., et al. Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatin. Cardiovasc. Drugs Ther. 2009, 23:215-220.
29. Suzuki J., Jin Z.G., Meoli D.F., Matoba T., Berk B.C. Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells. Circ. Res. 2006, 98:811-817.
30. Viemann D., et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005, 105:2955-2962.
31. Vogl T., et al. MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 2004, 104:4260-4268.
32. Vukanic Z.S., Colic M., Dimitrijevic M. Effect of pentoxifylline on differentiation and maturation of human monocyte-derived dendritic cells in vitro. Int. Immunopharmacol. 2007, 7:167-174.
33. Wagner A.M., et al. Post-translational protein modifications in type 1 diabetes: a role for the repair enzyme protein-l-isoaspartate (d-aspartate) O-methyltransferase?. Diabetologia 2007, 50:676-681.
34. Wibaut-Berlaimont V., Randi A.M., Mandryko V., Lunnon M.W., Haskard D.O., Naoumova R.P. Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. J. Thromb. Haemost. 2005, 3:677-685.
35. Zhang M., Xu Y.J., Mengi S.A., Arneja A.S., Dhalla N.S. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp. Clin. Cardiol. 2004, 9:103-111.
36. Zhang M., Xu Y.J., Saini H.K., Turan B., Liu P.P., Dhalla N.S. Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H832-H839.